Biological Monitoring
Biological Monitoring · Biological Monitoring overview
Biological monitoring measures a chemical, its metabolite or a biological effect inside the worker's body — usually in urine — to verify that engineering controls, RPE and PPE are actually preventing absorbed dose. It complements air monitoring; it does not replace it.
What biological monitoring measures
Biological monitoring is the measurement of a substance or its metabolite in a biological matrix — most commonly urine, but also blood or exhaled air — to estimate the internal dose received by a worker from all routes of exposure. It captures inhalation and dermal uptake together, so it is uniquely placed to verify the real-world performance of a control regime.
Where personal air sampling answers the question 'how much was in the breathing zone?', biological monitoring answers 'how much has actually entered the body?'. For substances that absorb readily through skin — many solvents, isocyanates and pesticides — air monitoring alone systematically underestimates exposure.
When biological monitoring is required
In Great Britain, biological monitoring is explicitly required under the Control of Lead at Work Regulations 2002 (CLAW), where blood-lead and urinary-lead action and suspension levels are statutory. Under COSHH, regulation 10 health surveillance and regulation 7 control hierarchy duties strongly imply biological monitoring for substances with skin notation, low airborne occupational exposure limits, or where established Biological Monitoring Guidance Values (BMGVs) exist.
HSE publishes BMGVs for substances including MDI/TDI, chromium, mercury, butan-2-one, cyclohexanone and others. ACGIH publishes Biological Exposure Indices (BEIs) for a wider range of solvents, metals and pesticides. Both reference sets are used routinely by UK occupational hygienists to interpret results.
Where it sits in the hierarchy of control
Biological monitoring is a verification tool, not a control. It belongs at the bottom of the hierarchy alongside health surveillance — once elimination, substitution, engineering controls, administrative controls and PPE have been applied, biological monitoring evidences whether the residual exposure has been adequately controlled.
Findings feed back into the control regime: an elevated group mean should trigger a review of LEV performance, RPE fit and dermal hygiene, not simply more frequent sampling.
How a programme is delivered
A defensible biological monitoring programme is scoped against a documented exposure assessment, uses validated analytical methods at an accredited laboratory, samples to a sampling strategy matched to biomarker half-life, and reports results against established reference values with written interpretation. Workers must be informed and consented; results are confidential occupational health data.
Frequently asked questions
Is biological monitoring the same as health surveillance?
No. Health surveillance looks for early signs of ill-health caused by exposure. Biological monitoring measures the exposure itself by detecting the substance or its metabolite inside the body.
Does HSE require biological monitoring?
It is statutory only under CLAW 2002 for lead. Under COSHH it is strongly indicated whenever HSE has published a BMGV, when a substance has skin notation, or when air monitoring alone cannot reliably characterise exposure.
How often should monitoring be repeated?
For routine exposure verification, annual or biennial campaigns are typical. Quarterly or per-shift sampling is used when introducing a new process, after a control failure, or for high-hazard substances such as MDI or hexavalent chromium.
Related pages